Abiopharma

Novanta - Novanta Announces Financial Results for the Second Quarter 2025

Novanta Announces Financial Results for the Second Quarter 2025

New Form 8-K - Pediatrix Medical Group, Inc. Filed: 2025-08-05 AccNo: 0000950170-25-102375 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 8-K - Azenta, Inc. Filed: 2025-08-05 AccNo: 0001437749-25-024705 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

BD Businesses Become First in MedTech to Achieve HIRCs Diamond Badge Across All Supply Chain Resiliency Categories

Pfizer Inc. - Pfizer Reports Second-Quarter 2025 Results

Avanos Medical Announces Appointment of Scott Galovan as Senior Vice President, Chief Financial Officer; David Pacitti Appointed to Board of Directors

New Form 10-Q - Vigil Neuroscience, Inc. Filed: 2025-08-05 AccNo: 0000950170-25-102371 Size: 8 MB

Pfizer Reports Strong Second-Quarter 2025 Results And Raises 2025 EPS Guidance

New Form 8-K - Shattuck Labs, Inc. Filed: 2025-08-05 AccNo: 0001193125-25-173010 Size: 842 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes USA - English India - English

New Form 6-K - SOPHiA GENETICS SA Filed: 2025-08-05 AccNo: 0001840706-25-000026 Size: 5 MB

New Form 10-Q - RECURSION PHARMACEUTICALS, INC. Filed: 2025-08-05 AccNo: 0001601830-25-000127 Size: 9 MB

Avanos Medical, Inc. Announces Second Quarter 2025 Results

Recursion Reports Second Quarter 2025 Financial Results and Provides Business Update